Regulatory status: For research use only, not for use in diagnostic procedures.
| No. | Components | Size | Storage Conditions |
| 1 | Microtiter plate | 96 wells coated with antigen | 2-8°C |
| 2 | Standard solutions | 6×1ml/bottle: 0ppb, 0.5ppb,1.5ppb, 4.5ppb,13.5ppb,40.5ppb | 2-8°C |
| 3 | Spiking standard solution | 1ml/bottle 1ppm | 2-8°C |
| 4 | Enzyme conjugate | 7ml | 2-8°C |
| 5 | Antibody solution | 7ml | 2-8°C |
| 6 | Substrate solution A | 7ml | 2-8°C |
| 7 | Substrate solution B | 7ml | 2-8°C |
| 8 | Stop solution | 7ml | 2-8°C |
| 9 | 20×concentrated wash solution | 40ml | 2-8°C |
| 10 | 4×Concentrated extraction solution | 50ml | 2-8°C |
| Product Name | Cat. No. | Applications | Host Species | Datasheet | Price | Add to Basket |
|---|
| Product Name | Cat. No. | Applications | Host Species | Datasheet | Price | Add to Basket |
|---|
Q: Does the U.S. Food and Drug Administration (FDA) have regulations on the residue limit of Tilmicosin? Can you provide the residue limit in ppb and the corresponding reference materials?
A: The FDA has not set a clear residue limit (MRL) for Tilmicosin. However, according to European regulations and the Turkish Food Code, the maximum residue limit for Tilmicosin in beef is 75 μg/kg and the maximum residue limit in pork is 50 μg/kg. (μg/kg = 1 ppb (part per billion) = 1 microgram of element per kilogram)
Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease
VETERINARY THERAPEUTICS
Authors: Kilgore, WR; Nutsch, RG; Spensley, MS; Rooney, KA; Sun, FS; Skogerboe, TL
Efficacy of tulathromycin versus enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves
VETERINARY THERAPEUTICS
Authors: Robb, Edward J.; Tucker, Cassius M.; Corley, Lane; Bryson, W. Lawrence; Rogers, Karen C.; Sturgess, Kynan; Bade, Donald J.; Brodersen, Bruce